114 related articles for article (PubMed ID: 1412120)
1. Nilutamide pneumonitis: a report on eight patients.
Pfitzenmeyer P; Foucher P; Piard F; Coudert B; Braud ML; Gabez P; Lacroix S; Mabille JP; Camus P
Thorax; 1992 Aug; 47(8):622-7. PubMed ID: 1412120
[TBL] [Abstract][Full Text] [Related]
2. Provocation test coupled with bronchoalveolar lavage in diagnosis of drug (nilutamide)-induced hypersensitivity pneumonitis.
Akoun GM; Liote HA; Liote F; Gauthier-Rahman S; Kuntz D
Chest; 1990 Feb; 97(2):495-8. PubMed ID: 2298082
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.
Gomez JL; Dupont A; Cusan L; Tremblay M; Tremblay M; Labrie F
Am J Med; 1992 May; 92(5):563-6. PubMed ID: 1580304
[TBL] [Abstract][Full Text] [Related]
4. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.
Kassouf W; Tanguay S; Aprikian AG
J Urol; 2003 May; 169(5):1742-4. PubMed ID: 12686822
[TBL] [Abstract][Full Text] [Related]
5. Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial.
Janknegt RA; Abbou CC; Bartoletti R; Bernstein-Hahn L; Bracken B; Brisset JM; Da Silva FC; Chisholm G; Crawford ED; Debruyne FM
J Urol; 1993 Jan; 149(1):77-82; discussion 83. PubMed ID: 7678043
[TBL] [Abstract][Full Text] [Related]
6. Nilutamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.
Harris MG; Coleman SG; Faulds D; Chrisp P
Drugs Aging; 1993; 3(1):9-25. PubMed ID: 8453188
[TBL] [Abstract][Full Text] [Related]
7. [Respiratory side-effects of drugs].
van der Drift MA; Kaajan JP
Ned Tijdschr Geneeskd; 2002 Jan; 146(4):145-50. PubMed ID: 11845561
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
Nakabayashi M; Regan MM; Lifsey D; Kantoff PW; Taplin ME; Sartor O; Oh WK
BJU Int; 2005 Oct; 96(6):783-6. PubMed ID: 16153200
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary complications of hormone treatment in prostate carcinoma.
Seigneur J; Trechot PF; Hubert J; Lamy P
Chest; 1988 May; 93(5):1106. PubMed ID: 3129240
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary toxicity of nilutamide (Anandron). Cooperative evaluation of French Regional Pharmacovigilance Centers].
Jonville AP; Diot E; Dutertre JP; Autret E
Therapie; 1992; 47(5):393-7. PubMed ID: 1299978
[TBL] [Abstract][Full Text] [Related]
11. Nilutamide: an antiandrogen for the treatment of prostate cancer.
Dole EJ; Holdsworth MT
Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
[TBL] [Abstract][Full Text] [Related]
12. A controlled trial of castration with and without nilutamide in metastatic prostatic carcinoma.
BĂ©land G; Elhilali M; Fradet Y; Laroche B; Ramsey EW; Trachtenberg J; Venner PM; Tewari HD
Cancer; 1990 Sep; 66(5 Suppl):1074-9. PubMed ID: 2203517
[TBL] [Abstract][Full Text] [Related]
13. Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide).
Kuhn JM; Billebaud T; Navratil H; Moulonguet A; Fiet J; Grise P; Louis JF; Costa P; Husson JM; Dahan R
N Engl J Med; 1989 Aug; 321(7):413-8. PubMed ID: 2503723
[TBL] [Abstract][Full Text] [Related]
14. Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project.
Decensi AU; Boccardo F; Guarneri D; Positano N; Paoletti MC; Costantini M; Martorana G; Giuliani L
J Urol; 1991 Aug; 146(2):377-81. PubMed ID: 1856935
[TBL] [Abstract][Full Text] [Related]
15. Nilutamide-induced neutropenia.
Eaton VS; Blackmore TK
BJU Int; 2001 Nov; 88(7):801-2. PubMed ID: 11890258
[No Abstract] [Full Text] [Related]
16. A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.
Davis NB; Ryan CW; Stadler WM; Vogelzang NJ
BJU Int; 2005 Oct; 96(6):787-90. PubMed ID: 16153201
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and metabolism of nilutamide.
Creaven PJ; Pendyala L; Tremblay D
Urology; 1991; 37(2 Suppl):13-9. PubMed ID: 1992598
[TBL] [Abstract][Full Text] [Related]
18. [Fatal fulminating hepatitis induced by nilutamide].
Edouard A; Robinel R; Rat C; Lombard F; Lorinet C; Escarmant P
Gastroenterol Clin Biol; 2003 Dec; 27(12):1170-1. PubMed ID: 14770126
[No Abstract] [Full Text] [Related]
19. [Nilutamide-induced acute hepatitis].
Hammel P; Ducreux M; Bismuth E; Ladouch-Badre A; Benoit G; Buffet C; Etienne JP
Gastroenterol Clin Biol; 1991; 15(6-7):557. PubMed ID: 1916139
[No Abstract] [Full Text] [Related]
20. [Acute depressive syndrome possibly due to nilutamide (Anandron) treatment].
Maroy B; Pitrou P
Therapie; 1997; 52(1):79-81. PubMed ID: 9183930
[No Abstract] [Full Text] [Related]
[Next] [New Search]